Latest filingSep 09, 2026Most recent Form 4
HRMY
Harmony Biosciences Holdings, Inc.
Insider activity for last month from 08/10 to 09/10. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$145M4 sells
Net open-market-$145M1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period8transactions
- M · Option exercise · dominant4 · 50%
- S · Open-market sells4 · 50%
Activity by reported role
A joint filing can contribute to multiple roles8transactions
- CMO · dominant8 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBudur KumarCommon Stock · Direct
13,115Sep 08, 2026
Budur KumarStock Option · Direct
64,246Sep 08, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 10 → Sep 10
LessMore
Top insiders
By absolute net value across the selected period- BK-$753.2k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
HRMY transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| HRMY | Budur Kumar | CMO | exercise10b5-1 | 10.7k | $0 | M | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | exercise10b5-1 | 12.2k | $0 | M | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | sale10b5-1 | 22.9k | -$98.9M | S | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | exercise10b5-1 | 10.7k | $32.5M | M | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | exercise10b5-1 | 12.2k | $37.4M | M | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | sale10b5-1 | 1.00k | -$4.27M | S | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | sale10b5-1 | 4.50k | -$19.0M | S | — | — | 09/09 | 09/08 |
| HRMY | Budur Kumar | CMO | sale10b5-1 | 5.50k | -$23.0M | S | — | — | 09/09 | 09/04 |
Harmony Biosciences Holdings, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Harmony Biosciences Holdings, Inc.?
Budur Kumar.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Budur Kumar reported a sale on Sep 08, 2026 valued at $98.9M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,453,169.44. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.